NCT00311519View on ClinicalTrials.gov

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

January 31, 2006

Conditions
Healthy
Interventions
DRUG

Hylenex

Trial Locations (1)

90806-2325

West Coast Clinical Trials, Long Beach

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY